[Behavior and functional state of the dopaminergic brain system in pups of depressive WAG/Rij rats].
In the present work, it has been studied for the first time behavior and functional state of the dopaminergic brain system in pups of "depressive" WAG/Rij rats. Offspring of "depressive" WAG/Rij rats at age of 6-16 days compared with offspring of "normal" (non-depressed) outbred rats of the same age exhibited reduced rate of pshychomotor development, lower body weight, attenuation in integration of coordinated reflexes and vestibular function (greater latency of righting reflex, abnormal negative geotaxis), hyper-reactivity to tactile stimulation, reduced motivation to contact with mother (reduced infant-mother attachment). Differences in a nest seeking response induced by olfactory stimuli (olfactory discrimination test) and in locomotor activity (tests "gait reflex" and "small open field") have not been revealed. Acute injection of the antagonist of D2-like dopamine receptors clebopride 20 min before testing aggravated mother-oriented behavior in 15-days-old pups of both "depressive" and "non-depressive" rats. However this effect was greater in pups of "depressive" WAG/Rij rats compared with pups of "normal" rats that may indicate reduced functional activity of the dopaminergic brain system in offspring of "depressive" rats. It is proposed that reduced attachment behavior in pups of "depressive" WAG/Rij rats might be a consequence of maternal depression and associated with it reduced maternal care. Moreover, reduced attachment behavior in pups of "depressive" rats might be an early precursor (a marker) of depressive-like pathology which become apparent later in life (approximately at age of 3 months).
A V
AV
Malyshev
E V
EV
Razumkina
É Ia
ÉIa
Rogozinskaia
K Iu
KIu
Sarkisova
V A
VA
Dybynin
D000818:Animals; D000831:Animals, Newborn; D001522:Behavior, Animal / Q000187:drug effects; D001549:Benzamides / Q000494:pharmacology; D001835:Body Weight; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D003863:Depression / Q000378:metabolism / Q000503:physiopathology* / Q000523:psychology; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists / Q000494:pharmacology; D059290:Dopaminergic Neurons / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D005260:Female; D006930:Hyperalgesia / Q000378:metabolism / Q000503:physiopathology* / Q000523:psychology; D008297:Male; D009769:Object Attachment; D011597:Psychomotor Performance / Q000187:drug effects; D051381:Rats; D012021:Reflex, Abnormal / Q000187:drug effects; D014724:Vestibular Function Tests
D001549:Benzamides; D018492:Dopamine Antagonists; C014417:clebopride; D004298:Dopamine